
Orcirab 20mg Tablet
Marketer
Iva Healthcare Pvt. Ltd.
Salt Composition
Rabeprazole (20mg)
Overview Orcirab 20mg Tablet
Gastracid 20mg tablets diminish stomach acid production. They treat acid-related disorders affecting the stomach and intestines, including gastroesophageal reflux disease, peptic ulcers, and Zollinger-Ellison syndrome, easing symptoms and aiding healing. Take one tablet an hour before meals, ideally in the morning, as directed by your physician; dosage varies based on individual needs and response. Consistent daily timing is crucial, even with rapid symptom improvement. Lifestyle adjustments, such as smaller, more frequent meals and avoiding caffeine, spicy foods, and fatty foods, can offer additional benefit. Common, generally mild, side effects include nausea, vomiting, headache, dizziness, gas, diarrhea, and abdominal pain. Persistent or bothersome effects warrant medical consultation. Prolonged use (over a year), particularly at higher doses, elevates bone fracture risk. Discuss bone health preservation strategies, including calcium and vitamin D supplementation, with your doctor. Hypomagnesemia (low magnesium) may develop after three months or more of use, potentially causing fatigue, confusion, dizziness, muscle spasms, and irregular heartbeat. Your doctor might monitor magnesium levels. This medication isn't suitable for everyone. Inform your physician of severe liver disease, HIV medication use, past allergic reactions to similar drugs, pre-existing osteoporosis, or pregnancy/breastfeeding before starting treatment. Alcohol should be avoided due to its acid-increasing effect. Refrain from operating machinery if dizziness or drowsiness occurs.
Uses of Orcirab 20mg Tablet
Management of gastroesophageal reflux disorder (GERD), peptic ulcers, and Zollinger-Ellison syndrome.
Major Benefits of Orcirab 20mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment schedule. Ingest the 20mg Orcirab tablet whole; avoid chewing, crushing, or fracturing it. Administer on an empty stomach.
Common Side effects of Orcirab 20mg Tablet:
- Diarrhea
- Dizziness
- Flatulence
- Headache
- Nausea
- Sore throat
- Stomach pain
- Vomiting
How to use Orcirab 20mg Tablet:
Follow your doctor's instructions precisely regarding dosage and treatment length for this medication. Ingest the 20mg Orcirab tablet whole; do not crush, chew, or break it. Administer on an empty stomach.
How Orcirab 20mg Tablet works:
Gastric acid production is decreased by the proton pump inhibitor (PPI) Orcirab 20mg Tablet, providing relief from heartburn and acid indigestion.
SAFETY ADVICE
AlcoholCAUTION
It's recommended to avoid alcohol while taking Orcirab 20mg tablets. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
The use of Orcirab 20mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the potential benefits against the risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
The use of Orcirab 20mg Tablet while breastfeeding is likely inadvisable. Available human data indicates potential transfer of the medication into breast milk, posing a possible risk to the infant.
DrivingUNSAFE
Taking a 20mg Orcirab tablet might reduce alertness, impair vision, and cause drowsiness or dizziness. Refrain from driving if you experience these effects.
KidneySAFE IF PRESCRIBED
Patients with kidney disease can safely use Orcirab 20mg Tablet without requiring a change in dosage.
LiverSAFE IF PRESCRIBED
Orcirab 20mg tablets pose no safety concerns for patients with hepatic impairment; no dosage modification is necessary.
What if you forget to take Orcirab 20mg Tablet :
Should you forget a dose of Orcirab 20mg Tablet, administer it at your earliest convenience. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Orcirab 20mg Tablet
| Label | Value |
|---|---|
| Chemical Type | Benzimidazole Sulfoxide |
| Developing Habits | No. |
| Treatment Category | Gastrointestinal system |
| Behavior Class | Gastric acid suppressants |
